Condition: Epilepsies, Partial · Epilepsy, Tonic-Clonic · Sponsor: Affiliated Hospital of Nantong University
This study primarily aims to assess the efficacy and safety of zonisamide when used as an adjunctive therapy for focal epilepsy. The main questions it aims to answer are: 1. Does the frequency of epileptic seizures decrease after oral zonisamide， and does it improve cognitive function? 2. Are there any treatment-emergent adverse events associated with oral administration of zonisamide?
This description comes directly from the study's public registry record.
youjia Y Wu, Doctorate · 13962969655 · francis_nt@163.com
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Nantong University | Nantong, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06967012